» Articles » PMID: 19228224

Clinical Guidelines for Overactive Bladder

Overview
Journal Int J Urol
Specialty Urology
Date 2009 Feb 21
PMID 19228224
Citations 46
Authors
Affiliations
Soon will be listed here.
Citing Articles

Prevalence and risk factors for overactive bladder symptoms in patients with artificial urinary sphincter.

Taniguchi H, Takizawa N, Kinoshita H Sci Rep. 2024; 14(1):20332.

PMID: 39223151 PMC: 11369108. DOI: 10.1038/s41598-024-68313-x.


Unsupervised Machine Learning Reveals a Vulvodynia-Predominant Subtype in Bladder Pain Syndrome/Interstitial Cystitis.

Okui N Cureus. 2024; 16(6):e62585.

PMID: 39027744 PMC: 11257649. DOI: 10.7759/cureus.62585.


The Clinical Study on Short-Term Efficacy of Pelvic Magnetic Stimulation Combined with Pelvic Muscle Biofeedback on Female Idiopathic Overactive Bladder.

Xiaofang L, Fang L, Shuang L, Zongjie L, Quanjiang H, Yan M J Womens Health Dev. 2023; 6(1):31-35.

PMID: 37168527 PMC: 10167738. DOI: 10.26502/fjwhd.2644-288400105.


Prevalence, Risk Factors, and Psychological Effects of Overactive Bladder in Chinese University Students.

Liang Y, Si G, Hu H, Zhang Z, Song C, Dou Q Int Neurourol J. 2023; 26(4):342-348.

PMID: 36599343 PMC: 9816442. DOI: 10.5213/inj.2244188.094.


Does metabolic syndrome influence the efficacy of mirabegron treatment in female patients with overactive bladder?.

Kinjo M, Masuda K, Nakamura Y, Taguchi S, Tambo M, Fukuhara H Int Urogynecol J. 2022; 34(4):853-859.

PMID: 35699775 DOI: 10.1007/s00192-022-05261-y.